Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01918800 · ClinicalTrials.gov registry record · NA
A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 282
- Enrollment target
NCT01918800: Completed NA study, sponsored by VA Office of Research and Development.
NCT01918800 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 282 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01918800, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 282 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different educational programs for people with multiple sclerosis (MS), which is a common and often disabling disease of the central nervous system. MS causes many symptoms including difficulty walking, loss of balance or muscle coordination, fatigue, numbness and tingling and stiffness. The investigators want to determine which program is better at helping improve quality of life and MS symptoms. Both programs use material from the National Multiple Sclerosis Society (NMSS). Both programs include 6 weekly 2-hour class sessions. Up to 600 participants will be enrolled total in 4 VA sites, with about 150 at each site. There will be 10 study visits, all to occur within 11 months. These include 1 baseline visit, 6 two-hour class visits, and 3 follow-up data collection visits. The participants in Portland will also participate in a final 12 month followup visit. Participants will be randomly (by chance) assigned to be part of either group education program. They will have a 1:1 or 50% chance of being in either program.
Interventions
- BEHAVIORAL Fatigue: Take control
- BEHAVIORAL MS: Take Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2013-03-28 |
| Est. Completion | 2015-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01918800
The ClinicalTrials.gov registry entry for NCT01918800 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fatigue: Take control is the first listed.
NCT01918800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01918800 about?
NCT01918800 is a clinical study titled "A Randomized Trial of Two Formal Group Programs for Multiple Sclerosis". The purpose of this study is to compare two different educational programs for people with multiple sclerosis (MS), which is a common and often disabling disease of the central nervous system. MS causes many symptoms including difficulty walking, loss of balance or muscle coordination, fatigue, numb...
What is the current status of trial NCT01918800?
This trial is currently completed. It is a NA study. The enrollment target is 282 participants. The study started on 2013-03-28. Estimated completion is 2015-12-30.
What interventions are being tested in trial NCT01918800?
The interventions under investigation include: Fatigue: Take control (BEHAVIORAL), MS: Take Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT01918800?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.